SCHEMBL23766378

SCHEMBL23766378

CC(C)(C)c1nc2c3ccccc3oc2c2c3ccccc3n(-c3ccccc3)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ SMN1; SMN2 Q16637 5/20 0.38
▸ LMNA P02545 3/20 0.38
▸ KDM4E B2RXH2 4/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ MAPT P10636 3/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ ATM Q13315 2/20 0.36
▸ TP53 P04637 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ HCRTR1 O43613 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23766342 0.82 POLB (0.39) CA12CA9SMN1; SMN2LMNAKDM4E
SCHEMBL23766348 0.78 SMN1; SMN2 (0.40) CA12CA9SMN1; SMN2LMNAKDM4E
SCHEMBL23766322 0.76 ALDH1A1 (0.40) CA12CA9SMN1; SMN2LMNAKDM4E
SCHEMBL17405384 0.76 KDM4E (0.47) CA12CA9SMN1; SMN2LMNAKDM4E
SCHEMBL16275339 0.76 KDM4E (0.47) CA12CA9SMN1; SMN2LMNAKDM4E
SCHEMBL17405532 0.76 KDM4E (0.47) CA12CA9SMN1; SMN2LMNAKDM4E
SCHEMBL16275378 0.76 KDM4E (0.47) CA12CA9SMN1; SMN2LMNAKDM4E
SCHEMBL17405930 0.74 KDM4E (0.46) CA12CA9SMN1; SMN2LMNAKDM4E
SCHEMBL17405731 0.74 KDM4E (0.46) CA12CA9SMN1; SMN2LMNAKDM4E
SCHEMBL16275310 0.74 KDM4E (0.46) CA12CA9SMN1; SMN2LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210257557-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2021-08-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210257557-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OSBP, OTC, OSBPL3 CA12 4402/4885CA9 3677/4885SMN1; SMN2 3352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback